Royalty Pharma Statistics
NASDAQ: RPRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
56.76+0.32 (+0.57%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Royalty Pharma by the numbers
Royalty Pharma has a market capitalization of $32.80 billion based on 445.28M shares outstanding. Its trailing P/E ratio is 30.2, above the 5-company peer median of 28.9, and its forward P/E is 9.9. The stock trades 4.3% below its 50-day average and 10.7% above its 200-day average.
Average daily trading volume is 2.92M shares, or about $165.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RPRX valuation vs. peer median
| Metric | RPRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $32.80B | $24.24B | +35% |
| P/E (TTM) | 30.2 | 28.9 | +5% |
| Forward P/E | 9.9 | 18.0 | -45% |
| Avg. volume | 2.92M | 2.67M | +9% |
Peer median across 8 companies: ALNY, ZTS, ROIV, ONC, UTHR, GMAB, INSM, VTRS.
Valuation
- Market cap
- $32.80B
- P/E (TTM)
- 30.19
- Forward P/E
- 9.90
- Price / sales (latest FY)
- 13.79
- EPS (TTM)
- $1.88
- Shares outstanding
- 445.28M
Price and trading
- Previous close
- 56.44
- Open
- 56.61
- Day range
- 56.41 – 57.16
- 52-week range
- 35.23 – 64.38
- 52-week change
- +57.23%
- Beta
- —
- Volume
- 3.67M
- Average volume
- 2.92M
Dividends and events
- Annual dividend
- $0.91
- Dividend yield
- 1.60%
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 32.80B
- Pe
- 30.19
- Forward Pe
- 9.90
- Eps
- 1.88
- Dividend Yield
- 1.66%
- Dividend Rate
- 0.91
- Week52 High
- 64.38
- Week52 Low
- 35.23
- Avg Volume
- 2.92M
- Shares Outstanding
- 445.28M
- Ma50
- 59.33
- Ma200
- 51.26
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -11.84%
- Pct From52w Low
- 61.11%